Cargando…
AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial
BACKGROUND: The evidence on the efficacy and safety of Ayurveda interventions as an add-on to the standard conventional care for coronavirus disease-2019 (COVID-19) is limited. AIM AND OBJECTIVE: This study was planned to explore the potential of AYUSH-64 as an add-on to conventional care in improvi...
Autores principales: | Reddy, R. Govind, Gosavi, Rajesh Vithal, Yadav, Babita, Rai, Amit Kumar, Holay, Madhuri Prashant, Talekar, Manisha, Jameela, Sophia, Sharma, Bhagwan Sahay, Khanduri, Shruti, Rana, Rakesh, Tripathi, Arunabh, Chandrasekhararao, Bhogavalli, Srikanth, Narayanam, Dhiman, Kartar S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614205/ https://www.ncbi.nlm.nih.gov/pubmed/34908795 http://dx.doi.org/10.4103/ayu.ayu_14_21 |
Ejemplares similares
-
Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional Analysis
por: Srikanth, Narayanam, et al.
Publicado: (2022) -
Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
por: Rai, Amit Kumar, et al.
Publicado: (2022) -
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
por: Singh, Harbans, et al.
Publicado: (2022) -
Efficacy and safety of Guduchighana Vati in asymptomatic and mild-to-moderate cases of coronavirus disease-19: A randomized controlled pilot study
por: Shukla, Umesh, et al.
Publicado: (2020) -
Dhatri Lauha in the management of iron deficiency anemia: A prospective open-label single-arm multi-center trial
por: Srikanth, Narayanam, et al.
Publicado: (2021)